Last reviewed · How we verify
NCT06277414
a Prediction of Post-Endoscopic Retrograde Cholangiopancreatography Complication
trial testing collection of laboratory test results, imaging results and symptoms in Endoscopic Retrograde Cholangiopancreatography in 2,000 participants. Status unknown.
31 December 2024
Quick facts
| Lead sponsor | The First Affiliated Hospital of University of South China |
|---|---|
| Status | Status unknown |
| Study type | OBSERVATIONAL |
| Enrollment | 2,000 |
| Start date | 1 January 2018 |
| Primary completion | 31 December 2024 |
| Estimated completion | 31 December 2024 |
| Sites | 1 location across China |
Drugs / interventions tested
- collection of laboratory test results, imaging results and symptoms
Conditions studied
- Endoscopic Retrograde Cholangiopancreatography — all drugs for Endoscopic Retrograde Cholangiopancreatography →
Sponsor
The First Affiliated Hospital of University of South China
Who can join
Adults 18 to 90, any sex, with Endoscopic Retrograde Cholangiopancreatography. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
To develop effective preoperative and postoperative prediction models for postoperative complications of ERCP
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT06277414
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Endoscopic Retrograde Cholangiopancreatography
Currently open trials in the same condition.
- NCT07440342 — TEAS for Sedation During ERCP: A Multicenter Trial · NA · recruiting
- NCT06716541 — Biodegradable Stents in Liver Transplant RecipIents for Treatment of Biliary Anastomotic Strictures · NA · recruiting
- NCT06776874 — Observational Study to Develop a Predictive Score for Adverse Events Post ERCP · recruiting
- NCT04408482 — Does Pancreatic Stent Decrease the Risk of Pancreatitis After Pancreatic Sphincterotomy for Difficult Cannulation? · NA · recruiting
Other The First Affiliated Hospital of University of South China trials
Trials by the same sponsor.
- NCT07147335 — The Role of Serum AKR1B10 in Early Warning of Hepatocellular Carcinoma in Cirrhosis Patients · recruiting
- NCT06979037 — Genetic Markers of Diabetic Ulcers and Personalized Treatment Targets Research · recruiting
- NCT06492811 — Efficacy and Safety of a Hydrogel Containing Cascade Catalytic Enzymes in the Treatment of Diabetic Wounds · Phase 2 · active not recruiting
- NCT05755594 — A Prospective Study on the Safety and Efficacy of Robot-assisted Pancreaticoduodenectomy · NA · not yet recruiting
- NCT05755607 — A Multicenter Prospective Randomized Controlled Study of RPD Versus LPD · NA · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT06277414 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by The First Affiliated Hospital of University of South China
- Last refreshed: 26 February 2024
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06277414.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing